Imaging & Diagnostics Geneoscopy Launches Colosense: New At-Home Colorectal Cancer Test
Geneoscopy, a healthcare company, has announced the commercial launch of Colosense, a groundbreaking at-home colorectal cancer screening test. This innovative, noninvasive test comes on the heels of an impressive $105 million funding round and FDA approval, positioning Colosense as a major player
Feb 17, 2025